These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
477 related articles for article (PubMed ID: 28819043)
1. Increased acetylation of microtubules rescues human tau-induced microtubule defects and neuromuscular junction abnormalities in Mao CX; Wen X; Jin S; Zhang YQ Dis Model Mech; 2017 Oct; 10(10):1245-1252. PubMed ID: 28819043 [TBL] [Abstract][Full Text] [Related]
2. HDAC6 mutations rescue human tau-induced microtubule defects in Drosophila. Xiong Y; Zhao K; Wu J; Xu Z; Jin S; Zhang YQ Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4604-9. PubMed ID: 23487739 [TBL] [Abstract][Full Text] [Related]
3. HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes. Noack M; Leyk J; Richter-Landsberg C Glia; 2014 Apr; 62(4):535-47. PubMed ID: 24464872 [TBL] [Abstract][Full Text] [Related]
4. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function. Carlomagno Y; Chung DC; Yue M; Castanedes-Casey M; Madden BJ; Dunmore J; Tong J; DeTure M; Dickson DW; Petrucelli L; Cook C J Biol Chem; 2017 Sep; 292(37):15277-15286. PubMed ID: 28760828 [TBL] [Abstract][Full Text] [Related]
5. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein. Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038 [TBL] [Abstract][Full Text] [Related]
6. Acetylation as a major determinant to microtubule-dependent autophagy: Relevance to Alzheimer's and Parkinson disease pathology. Esteves AR; Palma AM; Gomes R; Santos D; Silva DF; Cardoso SM Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2008-2023. PubMed ID: 30572013 [TBL] [Abstract][Full Text] [Related]
8. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model. Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cells. Asthana J; Kapoor S; Mohan R; Panda D J Biol Chem; 2013 Aug; 288(31):22516-26. PubMed ID: 23798680 [TBL] [Abstract][Full Text] [Related]
10. A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer's disease and tauopathy in mice. Onishi T; Maeda R; Terada M; Sato S; Fujii T; Ito M; Hashikami K; Kawamoto T; Tanaka M Sci Rep; 2021 Jul; 11(1):15423. PubMed ID: 34326423 [TBL] [Abstract][Full Text] [Related]
11. A comparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies. Ubhi KK; Shaibah H; Newman TA; Shepherd D; Mudher A Invert Neurosci; 2007 Sep; 7(3):165-71. PubMed ID: 17636367 [TBL] [Abstract][Full Text] [Related]
12. HDAC6 regulates microtubule stability and clustering of AChRs at neuromuscular junctions. Osseni A; Ravel-Chapuis A; Thomas JL; Gache V; Schaeffer L; Jasmin BJ J Cell Biol; 2020 Aug; 219(8):. PubMed ID: 32697819 [TBL] [Abstract][Full Text] [Related]
14. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors. Gold WA; Lacina TA; Cantrill LC; Christodoulou J J Mol Med (Berl); 2015 Jan; 93(1):63-72. PubMed ID: 25209898 [TBL] [Abstract][Full Text] [Related]
15. Characterization of Brain-Penetrant Pyrimidine-Containing Molecules with Differential Microtubule-Stabilizing Activities Developed as Potential Therapeutic Agents for Alzheimer's Disease and Related Tauopathies. Kovalevich J; Cornec AS; Yao Y; James M; Crowe A; Lee VM; Trojanowski JQ; Smith AB; Ballatore C; Brunden KR J Pharmacol Exp Ther; 2016 May; 357(2):432-50. PubMed ID: 26980057 [TBL] [Abstract][Full Text] [Related]
16. Targeted Downregulation of dMyc Suppresses Pathogenesis of Human Neuronal Tauopathies in Drosophila by Limiting Heterochromatin Relaxation and Tau Hyperphosphorylation. Chanu SI; Sarkar S Mol Neurobiol; 2017 May; 54(4):2706-2719. PubMed ID: 27000837 [TBL] [Abstract][Full Text] [Related]
17. Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies. Venkatramani A; Panda D Int J Biol Macromol; 2019 Jul; 133():473-483. PubMed ID: 31004638 [TBL] [Abstract][Full Text] [Related]
18. Microtubule-severing protein Katanin regulates neuromuscular junction development and dendritic elaboration in Drosophila. Mao CX; Xiong Y; Xiong Z; Wang Q; Zhang YQ; Jin S Development; 2014 Mar; 141(5):1064-74. PubMed ID: 24550114 [TBL] [Abstract][Full Text] [Related]
19. Strategies for diminishing katanin-based loss of microtubules in tauopathic neurodegenerative diseases. Sudo H; Baas PW Hum Mol Genet; 2011 Feb; 20(4):763-78. PubMed ID: 21118899 [TBL] [Abstract][Full Text] [Related]
20. NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy. Quraishe S; Cowan CM; Mudher A Mol Psychiatry; 2013 Jul; 18(7):834-42. PubMed ID: 23587881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]